Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin, Metformin, and YH14755 PK and Food Effect Study
NCT02125227Phase 1Completed
- Sponsor
- Yuhan
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin + metformin in dyslipidemia and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma concentration-time curve from time 0 to the last measurable concentration and Maximum plasma concentration. Started Apr 2014; status: completed.
02
Drugs
rosuvastatin + metformin
03
Conditions
dyslipidemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02125227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125227.